These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 21368600)

  • 1. Incidence of second primary malignancies during a long-term surveillance of patients with differentiated thyroid carcinoma in relation to radioiodine treatment.
    Fallahi B; Adabi K; Majidi M; Fard-Esfahani A; Heshmat R; Larijani B; Haghpanah V
    Clin Nucl Med; 2011 Apr; 36(4):277-82. PubMed ID: 21368600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual malignancies in the setting of differentiated thyroid carcinoma: their synchronous or metachronous nature, impact of radioiodine treatment on occurrence of second malignancy and other associated variables.
    Gandhi S; Abhyankar A; Basu S
    Nucl Med Commun; 2014 Feb; 35(2):205-9. PubMed ID: 24217429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Should we routinely offer a second admission for radioiodine to patients with high-risk differentiated thyroid cancer?
    Gerrard GE; O'Toole L; Roberts F
    Clin Oncol (R Coll Radiol); 2010 Mar; 22(2):136-9. PubMed ID: 20152708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of second primary malignancy after radioactive iodine treatment for differentiated thyroid carcinoma.
    Bhattacharyya N; Chien W
    Ann Otol Rhinol Laryngol; 2006 Aug; 115(8):607-10. PubMed ID: 16944659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Second Primary Cancer in Patients with Differentiated Thyroid Cancer: Does Radioiodine Play a Role?
    Silva-Vieira M; Carrilho Vaz S; Esteves S; Ferreira TC; Limbert E; Salgado L; Leite V
    Thyroid; 2017 Aug; 27(8):1068-1076. PubMed ID: 28614983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of female fertility and carcinogenesis after iodine-131 therapy for differentiated thyroid carcinoma.
    Dottorini ME; Lomuscio G; Mazzucchelli L; Vignati A; Colombo L
    J Nucl Med; 1995 Jan; 36(1):21-7. PubMed ID: 7799075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delayed initial radioactive iodine therapy resulted in poor survival in patients with metastatic differentiated thyroid carcinoma: a retrospective statistical analysis of 198 cases.
    Higashi T; Nishii R; Yamada S; Nakamoto Y; Ishizu K; Kawase S; Togashi K; Itasaka S; Hiraoka M; Misaki T; Konishi J
    J Nucl Med; 2011 May; 52(5):683-9. PubMed ID: 21498534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The carcinogenic effects of radioiodine therapy for thyroid carcinoma.
    de Vathaire F
    Nat Clin Pract Endocrinol Metab; 2008 Apr; 4(4):180-1. PubMed ID: 18283326
    [No Abstract]   [Full Text] [Related]  

  • 9. Risk of second primary malignancy in differentiated thyroid carcinoma treated with radioactive iodine therapy.
    Lang BH; Wong IO; Wong KP; Cowling BJ; Wan KY
    Surgery; 2012 Jun; 151(6):844-50. PubMed ID: 22341041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of Nonthyroidal Primary Malignancy and the Association with (131)I Treatment in Patients with Differentiated Thyroid Cancer.
    Hirsch D; Shohat T; Gorshtein A; Robenshtok E; Shimon I; Benbassat C
    Thyroid; 2016 Aug; 26(8):1110-6. PubMed ID: 27302111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review.
    Jarzab B; Handkiewicz-Junak D; Wloch J
    Endocr Relat Cancer; 2005 Dec; 12(4):773-803. PubMed ID: 16322322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonthyroidal second primary malignancies in differentiated thyroid cancer patients: Is the incidence increased comparing to the general population and could it be a radioiodine therapy consequence?
    Cappagli V; Caldarella A; Manneschi G; Piaggi P; Bottici V; Agate L; Molinaro E; Bianchi F; Elisei R
    Int J Cancer; 2020 Nov; 147(10):2838-2846. PubMed ID: 32449158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Second malignancies after prostate brachytherapy: incidence of bladder and colorectal cancers in patients with 15 years of potential follow-up.
    Liauw SL; Sylvester JE; Morris CG; Blasko JC; Grimm PD
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):669-73. PubMed ID: 16887293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased risk of second primary malignancy in pediatric and young adult patients treated with radioactive iodine for differentiated thyroid cancer.
    Marti JL; Jain KS; Morris LG
    Thyroid; 2015 Jun; 25(6):681-7. PubMed ID: 25851829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Second neoplasms after megavoltage radiation for pediatric tumors.
    Gold DG; Neglia JP; Dusenbery KE
    Cancer; 2003 May; 97(10):2588-96. PubMed ID: 12733158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radioiodine treatment complications to the mother and child in patients with differentiated thyroid carcinoma.
    Fard-Esfahani A; Hadifar M; Fallahi B; Beiki D; Eftekhari M; Saghari M; Takavar A
    Hell J Nucl Med; 2009; 12(1):37-40. PubMed ID: 19330181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The risk of multiple primary breast and thyroid carcinomas.
    Adjadj E; Rubino C; Shamsaldim A; Lê MG; Schlumberger M; de Vathaire F
    Cancer; 2003 Sep; 98(6):1309-17. PubMed ID: 12973856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiated thyroid cancer in a Swedish county--long-term results and quality of life.
    Malterling RR; Andersson RE; Falkmer S; Falkmer U; Niléhn E; Järhult J
    Acta Oncol; 2010 May; 49(4):454-9. PubMed ID: 20092427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcomes of persistent radioiodine uptake in the neck shown by diagnostic whole body scan in patients with differentiated thyroid carcinoma after initial surgery and remnant ablation.
    Kim EY; Kim WG; Kim WB; Kim TY; Ryu JS; Gong G; Yoon JH; Hong SJ; Lee JH; Baek JH; Shong YK
    Clin Endocrinol (Oxf); 2010 Aug; 73(2):257-63. PubMed ID: 20105187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aspects of timing and selection of cases in radioiodine therapy and percutaneous irradiation of well differentiated carcinoma of the thyroid.
    Wiebe V; Schneider C; Franke HD
    Strahlentherapie; 1975 Jan; 149(1):55-9. PubMed ID: 1124555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.